GeneLink Lawsuit Dismissed | GenomeWeb

NEW YORK (GenomeWeb News) — A Pennsylvania court has dismissed a lawsuit by former GeneLink CEO John DePhillipo against the company, its marketing subsidiary GeneWize Life Sciences, and some of the company's executives, GeneLink said today.

The Philadelphia Court of Common Pleas dismissed the lawsuit — for damages that the plaintiff valued at around $20 million — on the grounds that DePhillipo's claims "were not viable," the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.